CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2590
-0.0078 (-2.92%)
Oct 20, 2025, 3:58 PM EDT
CytoDyn Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
336.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | - | - | - |
May 31, 2024 | - | - | - |
May 31, 2023 | - | - | - |
May 31, 2022 | 266.00K | - | - |
May 31, 2021 | - | - | - |
May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
China New Energy Group Co. | 12.51M |
Nuo Therapeutics | 1.95M |
CytoDyn News
- 11 days ago - CytoDyn to Present at the LD Micro Main Event XIX Investor Conference - GlobeNewsWire
- 20 days ago - September 2025 Letter to Shareholders - GlobeNewsWire
- 25 days ago - CytoDyn (CYDY) Highlights Promising Cancer Research at AACR Conference - GuruFocus
- 25 days ago - CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity - GlobeNewsWire
- 4 weeks ago - CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity - GlobeNewsWire
- 6 weeks ago - CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 weeks ago - CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - CytoDyn files $100M mixed securities shelf - Seeking Alpha